Mari Aksnes
Mari Aksnes
Background: Alzheimer's disease (AD), the most common cause of dementia, affects twice as many women as men. Moreover, sex is increasingly recognised as an important factor for AD, influencing symptom presentation, progre...
The genetic architecture of Parkinson's disease in Morocco: highlighting a predominance of Mendelian genes [0.03%]
摩洛哥帕金森病的遗传结构：侧重于揭示孟德尔基因的主导地位
Ahmed Bouhouche,Houyam Tibar,Wafa Regragui
Ahmed Bouhouche
Background: Parkinson's disease (PD), although widely heterogeneous and manifesting with numerous motor and non-motor symptoms, presents clinically as a single entity worldwide. Its genetic causes are also heterogeneous a...
Characteristics of Neuromuscular Ultrasound in Patients with Amyotrophic Lateral Sclerosis [0.03%]
肌萎缩侧索硬化患者神经肌肉超声的特征性变化
Jieying Wu,Hongsong Song,Mukadas Arkin et al.
Jieying Wu et al.
Introduction: Neuromuscular ultrasound has been increasingly used in the detection and diagnosis of amyotrophic lateral sclerosis (ALS), commonly characterized by peripheral nerve atrophy, degeneration, and muscle fascicu...
The glymphatic system in cerebrospinal fluid dynamics - clinical implications, its evaluation, and application to therapeutics [0.03%]
脑脊液动力学中的glymphatic系统及其临床意义、评估和治疗应用
Masahiro Ohara,Takaaki Hattori
Masahiro Ohara
Background: The glymphatic system is a waste clearance system that facilitates the efficient removal of interstitial solutes, including neurotoxic substances such as β-amyloid, from the central nervous system. Numerous s...
Published Erratum
Neuro-degenerative diseases. 2025 May 12;25(1):50. DOI:10.1159/000545725 2025
Active immunization targeting amyloid β for the treatment of Alzheimer's disease [0.03%]
针对阿尔茨海默病治疗的以淀粉样蛋白β为目标的主动免疫法
Olivia Triplett,Nicole Varda,Boris Decourt et al.
Olivia Triplett et al.
Background: Alzheimer's disease (AD) is the most prevalent neurodegenerative condition worldwide. It is characterized by the formation of amyloid beta (Aβ) plaques in the brain and by the accumulation of neurofibrillary ...
Paolo Salvioni Chiabotti,Giulia Bommarito,Patrik Michel et al.
Paolo Salvioni Chiabotti et al.
Letter - Expert Discussion Anti-amyloid treatments, a therapeutic revolution, ready for Europe. The Author(s). Published by S. Karger AG, Basel.
Anti-amyloid monoclonal antibodies for the treatment of Alzheimer disease: Intersocietal recommendations for their appropriate use in Switzerland [0.03%]
用于阿尔茨海默病治疗的抗淀粉样蛋白单克隆抗体：在瑞士适当使用的国际学会建议
Ansgar Felbecker,Olivier Rouaud,Aurelien Lathuilliere et al.
Ansgar Felbecker et al.
The association of Swiss Memory Clinics (SMC) provides intersocietal recommendations for the use of anti-amyloid monoclonal antibodies (mAbs) in Switzerland. The recommendations are the result of extensive interdisciplinary discussions in a...
Practice Guideline
Neuro-degenerative diseases. 2025 Apr 11. DOI:10.1159/000545799 2025
Alzheimer's disease, β-amyloid peptides and ubiquitin-proteasome system: nutritherapeutic insights [0.03%]
阿尔茨海默病，β-淀粉样肽和泛素蛋白酶体系统：营养治疗的见解
Philippe Yves Rémy Simon,Renaud David
Philippe Yves Rémy Simon
Background: The Alzheimer's disease - an age-related neurodegenerative disorder leading to a progressive cognitive impairment - is characterized by an intracerebral accumulation of soluble β-amyloid (Aβ) oligomers, foll...
Sex differences in progression of neurodegeneration: the AGES-Reykjavik Study [0.03%]
神经变性进展的性别差异：来自雷克雅未克年龄研究的结果
Emma L Twait,Vilmundur Gudnason,Lenore J Launer et al.
Emma L Twait et al.
Introduction: Advancing age is associated with global brain atrophy. Cross-sectional studies have found sex differences in neuroanatomy; however, longitudinal studies assessing sex differences in neurodegeneration are cur...